- Home
- RES vs PHAR Comparison
RES vs PHAR Comparison
Compare RES & PHAR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RES
- PHAR
- Stock Information
- Founded
- RES 1984
- PHAR 1988
- Country
- RES United States
- PHAR Netherlands
- Employees
- RES N/A
- PHAR N/A
- Industry
- RES Oilfield Services/Equipment
- PHAR Biotechnology: Pharmaceutical Preparations
- Sector
- RES Energy
- PHAR Health Care
- Exchange
- RES Nasdaq
- PHAR Nasdaq
- Market Cap
- RES 1.0B
- PHAR 1.0B
- IPO Year
- RES N/A
- PHAR N/A
- Fundamental
- Price
- RES $4.70
- PHAR $14.93
- Analyst Decision
- RES Hold
- PHAR Strong Buy
- Analyst Count
- RES 4
- PHAR 3
- Target Price
- RES $4.69
- PHAR $30.00
- AVG Volume (30 Days)
- RES 1.4M
- PHAR 11.5K
- Earning Date
- RES 10-23-2025
- PHAR 10-23-2025
- Dividend Yield
- RES 3.44%
- PHAR N/A
- EPS Growth
- RES N/A
- PHAR N/A
- EPS
- RES 0.25
- PHAR N/A
- Revenue
- RES $1,426,699,000.00
- PHAR $339,836,000.00
- Revenue This Year
- RES $11.80
- PHAR $16.63
- Revenue Next Year
- RES $6.13
- PHAR $6.77
- P/E Ratio
- RES $18.61
- PHAR N/A
- Revenue Growth
- RES N/A
- PHAR 22.44
- 52 Week Low
- RES $4.10
- PHAR $7.06
- 52 Week High
- RES $7.22
- PHAR $17.08
- Technical
- Relative Strength Index (RSI)
- RES 51.80
- PHAR 59.46
- Support Level
- RES $4.54
- PHAR $13.51
- Resistance Level
- RES $4.81
- PHAR $15.61
- Average True Range (ATR)
- RES 0.15
- PHAR 0.85
- MACD
- RES 0.01
- PHAR -0.04
- Stochastic Oscillator
- RES 55.17
- PHAR 72.60
About RES RPC Inc.
RPC Inc is an oilfield services company. It provides specialized oilfield services and equipment to independent and oil and gas companies engaged in the exploration, production, and development of oil and gas properties throughout the United States. The company's operating segment includes Technical Services and Support Services. It generates maximum revenue from the Technical Services segment. Technical Services segment nclude RPC's oil and gas services that utilize people and equipment to perform value-added completion, production and maintenance services directly to a customer's well. Support Services segment consists of drill pipe and related tools, pipe handling, pipe inspection and storage services, and oilfield training and consulting services.
About PHAR Pharming Group N.V.
Pharming Group is a biopharmaceutical company focused in transforming the lives of patients with rare, debilitating, and life-threatening diseases. The company is actively developing and commercializing a diverse portfolio of innovative treatments, including both biologics and small molecule therapies. Its commercial products are RUCONEST, approved for the treatment of acute attacks in adult and adolescent patients with hereditary angioedema, or HAE; and Joenja (leniolisib), a small-molecule kinase inhibitor, developed for the treatment of activated phosphoinositide 3-kinase delta syndrome.